Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' KUHLMANN J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 80 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Eisele, F; Kuhlmann, J; Waldmann, H
      Synthesis and membrane-binding properties of a characteristic lipopeptide from the membrane-anchoring domain of influenza virus A hemagglutinin

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    2. Kuhlmann, J; Herrmann, C
      Biophysical characterization of the Ras protein

      BIOORGANIC CHEMISTRY OF BIOLOGICAL SIGNAL TRANSDUCTION
    3. Kuhlmann, J; Muck, W
      Clinical-pharmacological strategies to assess drug interaction potential during drug development

      DRUG SAFETY
    4. Renault, L; Kuhlmann, J; Henkel, A; Wittinghofer, A
      Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1)

      CELL
    5. Bose, G; Kuhlmann, J; Plass, M; Muller, O
      Microplate enzyme-linked immunosorbent assay for the detection of primary DNA alterations based on the interaction with UvrA/UvrB

      ANALYTICAL BIOCHEMISTRY
    6. Kuhn, K; Owen, DJ; Bader, B; Wittinghofer, A; Kuhlmann, J; Waldmann, H
      Synthesis of functional Ras lipoproteins and fluorescent derivatives

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    7. Kadereit, D; Kuhlmann, J; Waldmann, H
      Linking the fields - The interplay of organic synthesis, biophysical chemistry, and cell biology in the chemical biology of protein lipidation

      CHEMBIOCHEM
    8. Erdmann, KS; Kuhlmann, J; Lessmann, V; Herrmann, L; Eulenburg, V; Muller, O; Heumann, R
      The Adenomatous Polyposis Coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain

      ONCOGENE
    9. Kuhlmann, J
      Tasks of clinical pharmacology in the early phase of drug development

      MEDIZINISCHE KLINIK
    10. Ahr, G; Voith, B; Kuhlmann, J
      Guidances related to bioavailability and bioequivalence: European industryperspective

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    11. Bader, B; Kuhn, K; Owen, DJ; Waldmann, H; Wittinghofer, A; Kuhlmann, J
      Bioorganic synthesis of lipid-modified proteins for the study of signal transduction

      NATURE
    12. Chaillan-Huntington, C; Braslavsky, CV; Kuhlmann, J; Stewart, M
      Dissecting the interactions between NTF2, RanGDP, and the nucleoporin XFXFG repeats

      JOURNAL OF BIOLOGICAL CHEMISTRY
    13. Braslavsky, CIV; Nowak, C; Gorlich, D; Wittinghofer, A; Kuhlmann, J
      Different structural and kinetic requirements for the interaction of Ran with the Ran-binding domains from RanBP2 and importin-beta

      BIOCHEMISTRY
    14. Schelhaas, M; Nagele, E; Kuder, N; Bader, B; Kuhlmann, J; Wittinghofer, A; Waldmann, H
      Chemoenzymatic synthesis of biotinylated Ras peptides and their use in membrane binding studies of lipidated model proteins by surface plasmon resonance

      CHEMISTRY-A EUROPEAN JOURNAL
    15. Cotte, A; Bader, B; Kuhlmann, J; Waldmann, H
      Synthesis of the N-terminal lipohexapeptide of human G(alpha o)-protein and fluorescent-labeled analogues for biological studies

      CHEMISTRY-A EUROPEAN JOURNAL
    16. Kuhlmann, J
      Alternative strategies in drug development: clinical pharmacological aspects

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    17. Schlupen, J; Haegel, FH; Kuhlmann, J; Geisler, H; Schwuger, MJ
      Sorption hysteresis of pyrene on zeolite

      COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
    18. Kuhlmann, J
      Tasks of clinical pharmacology in the early phase of drug development

      MEDIZINISCHE KLINIK
    19. Kuhlmann, J; Berger, W; Podzuweit, H; Schmidt, U
      The influence of valerian treatment on "Reaction time, alertness and concentration" in volunteers

      PHARMACOPSYCHIATRY
    20. Vormfelde, SV; Muck, W; Freudenthaler, SM; Heyen, P; Schmage, N; Kuhlmann, J; Muller, GA; Gundert-Remy, UM; Gleiter, CH
      Pharmacokinetics of cerivastatin in renal impairment are predicted by low serum albumin concentration rather than by low creatinine clearance

      JOURNAL OF CLINICAL PHARMACOLOGY
    21. Vetter, IR; Nowak, C; Nishimoto, T; Kuhlmann, J; Wittinghofer, A
      Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport

      NATURE
    22. Muck, W; Mai, I; Fritsche, L; Ochmann, K; Rohde, G; Unger, S; Johne, A; Bauer, S; Budde, K; Roots, I; Neumayer, HH; Kuhlmann, J
      Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    23. Geyer, M; Assheuer, R; Klebe, C; Kuhlmann, J; Becker, J; Wittinghofer, A; Kalbitzer, HR
      Conformational states of the nuclear GTP-binding protein Ran and its complexes with the exchange factor RCC1 and the effector protein RanBP1

      BIOCHEMISTRY
    24. SACHSE R; BRENDEL E; MUCK W; ROHDE G; OCHMANN K; HORSTMANN R; KUHLMANN J
      LACK OF DRUG-DRUG INTERACTION BETWEEN CERIVASTATIN AND NIFEDIPINE

      International journal of clinical pharmacology and therapeutics
    25. FUHR U; MAIERBRUGGEMANN A; BLUME H; MUCK W; UNGER S; KUHLMANN J; HUSCHKA C; ZAIGLER M; RIETBROCK S; STAIB AH
      GRAPEFRUIT JUICE INCREASES ORAL NIMODIPINE BIOAVAILABILITY

      International journal of clinical pharmacology and therapeutics
    26. KUHLMANN J
      HUMAN PHARMACOLOGY - CLINICAL-PHARMACOLOGY - COMMON GOALS AND TASKS FROM THE POINT-OF-VIEW OF THE DGPT SECTION CLINICAL-PHARMACOLOGY (GERMAN SOCIETY OF EXPERIMENTAL AND CLINICAL-PHARMACOLOGY AND TOXICOLOGY)

      International journal of clinical pharmacology and therapeutics
    27. GLEITER CH; KLOTZ U; KUHLMANN J; BLUME H; STANISLAUS F; HARDER S; PAULUS H
      WHEN ARE BIOAVAILABILITY STUDIES REQUIRED - A GERMAN PROPOSAL

      Journal of clinical pharmacology
    28. LEMM G; KUPPERS J; FREY R; WINGENDER W; KUHLMANN J
      MONITORING OF PROTEINURIA IN PHASE-I STUDIES IN HEALTHY MALE-SUBJECTS

      European Journal of Clinical Pharmacology
    29. MUCK W; OCHMANN K; ROHDE G; UNGER S; KUHLMANN J
      INFLUENCE OF ERYTHROMYCIN PRE-TREATMENT AND CO-TREATMENT ON SINGLE-DOSE PHARMACOKINETICS OF THE HMG-COA-REDUCTASE INHIBITOR CERIVASTATIN

      European Journal of Clinical Pharmacology
    30. MAI I; BAUER S; JOHNE A; FRITSCHE L; OCHMANN K; MUCK W; ROHDE G; ROOTS I; NEUMAYER HH; KUHLMANN J
      SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF A NEW HMG-COA REDUCTASE INHIBITOR IN RENAL-TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINE-A (CSA)

      Naunyn-Schmiedeberg's archives of pharmacology
    31. BIRKNER S; WEBER S; KUHLMANN J; MULLER O; FOLLMANN W
      DEVELOPMENT OF A NEW MOLECULAR BIOLOGICAL IN-VITRO ASSAY FOR TOXICOLOGICAL STUDIES USING CULTURED BOVINE URINARY-BLADDER EPITHELIAL-CELLS

      Naunyn-Schmiedeberg's archives of pharmacology
    32. VORMFELDE SV; MUCK W; KUHLMANN J; GLEITER CH
      DOES LOW SERUM-ALBUMIN CONCENTRATION OR CREATININE CLEARANCE PREDICT CERIVASTATIN PHARMACOKINETICS IN PATIENTS WITH RENAL IMPAIRMENT

      Naunyn-Schmiedeberg's archives of pharmacology
    33. MUCK W; OCHMANN K; ROHDE G; UNGER S; KUHLMANN J
      NO DRUG-DRUG INTERACTION BETWEEN CERIVASTATIN AND OMEPRAZOLE

      Naunyn-Schmiedeberg's archives of pharmacology
    34. FAIX J; CLOUGHERTY C; KONZOK A; MINTERT U; MURPHY J; ALBRECHT R; MUHLBAUER B; KUHLMANN J
      THE IQGAP-RELATED PROTEIN DGAP1 INTERACTS WITH RAC AND IS INVOLVED INTHE MODULATION OF THE F-ACTIN CYTOSKELETON AND CONTROL OF CELL MOTILITY

      Journal of Cell Science
    35. RUDOLPH MG; BAYER P; ABO A; KUHLMANN J; VETTER IR; WITTINGHOFER A
      THE CDC42 RAC INTERACTIVE BINDING REGION MOTIF OF THE WISKOTT-ALDRICH-SYNDROME PROTEIN (WASP) IS NECESSARY BUT NOT SUFFICIENT FOR TIGHT-BINDING TO CDC42 AND STRUCTURE FORMATION/

      The Journal of biological chemistry
    36. EHRICH M; KUHLMANN J
      TRANSIENT SHIELDING OF DATA-LINES BY A METAL PLATE OF RECTANGULAR CROSS-SECTION

      IEEE transactions on magnetics
    37. DEKA J; KUHLMANN J; MULLER O
      A DOMAIN WITHIN THE TUMOR-SUPPRESSOR PROTEIN APC SHOWS VERY SIMILAR BIOCHEMICAL-PROPERTIES AS THE MICROTUBULE-ASSOCIATED PROTEIN-TAU

      European journal of biochemistry
    38. LENZEN C; COOL RH; PRINZ H; KUHLMANN J; WITTINGHOFER A
      KINETIC-ANALYSIS BY FLUORESCENCE OF THE INTERACTION BETWEEN RAS AND THE CATALYTIC DOMAIN OF THE GUANINE-NUCLEOTIDE EXCHANGE FACTOR CDC25(MM)

      Biochemistry
    39. STAUDER H; HARING RB; HAUNS B; KUHLMANN J; MAIERLENZ H; MENG G; MROSS K; UNGER C
      PHASE-II STUDY WITH 5-FLUOROURACIL AND GINKGO-BILOBA EXTRACT IN PATIENTS WITH PANCREAS CA

      European journal of cancer
    40. HEINIG R; AHR G; HAYAUCHI Y; KUHLMANN J
      PHARMACOKINETICS OF THE CONTROLLED-RELEASE NISOLDIPINE COAT-CORE TABLET FORMULATION

      International journal of clinical pharmacology and therapeutics
    41. MUCK W; RITTER W; FREY R; WETZELSBERGER N; LUCKER PW; KUHLMANN J
      INFLUENCE OF CHOLESTYRAMINE ON THE PHARMACOKINETICS OF CERIVASTATIN

      International journal of clinical pharmacology and therapeutics
    42. MUCK W; RITTER W; OCHMANN K; UNGER S; AHR G; WINGENDER W; KUHLMANN J
      ABSOLUTE AND RELATIVE BIOAVAILABILITY OF THE HMG-COA REDUCTASE INHIBITOR CERIVASTATIN

      International journal of clinical pharmacology and therapeutics
    43. MUCK W; RITTER W; DIETRICH H; FREY R; KUHLMANN J
      INFLUENCE OF THE ANTACID MAALOX AND THE H-2-ANTAGONIST CIMETIDINE ON THE PHARMACOKINETICS OF CERIVASTATIN

      International journal of clinical pharmacology and therapeutics
    44. KUHLMANN J
      DRUG RESEARCH - FROM THE IDEA TO THE PRODUCT

      International journal of clinical pharmacology and therapeutics
    45. DOBOS GJ; BURGER M; KUHLMANN J; PASSLICKDEETJEN J; SCHOLLMEYER P; BOHLER J
      IMPROVED CYTOSOLIC-FREE CALCIUM MOBILIZATION AND SUPEROXIDE PRODUCTION IN BICARBONATE-BASED PERITONEAL-DIALYSIS SOLUTION

      Nephrology, dialysis, transplantation
    46. WALDMANN H; SCHELHAAS M; NAGELE E; KUHLMANN J; WITTINGHOFER A; SCHROEDER H; SILVIUS JR
      CHEMOENZYMATIC SYNTHESIS OF FLUORESCENT N-RAS LIPOPEPTIDES AND THEIR USE IN MEMBRANE LOCALIZATION STUDIES IN-VIVO

      Angewandte Chemie, International Edition in English
    47. SCHAEFER HG; HEINIG R; AHR G; ADELMANN H; TETZLOFF W; KUHLMANN J
      PHARMACOKINETIC-PHARMACODYNAMIC MODELING AS A TOOL TO EVALUATE THE CLINICAL RELEVANCE OF A DRUG-FOOD INTERACTION FOR A NISOLDIPINE CONTROLLED-RELEASE DOSAGE FORM

      European Journal of Clinical Pharmacology
    48. RITTER W; OCHMANN K; MUCK W; KUHLMANN J
      ABSOLUTE AND RELATIVE BIOAVAILABILITY OF THE HMG-COA REDUCTASE INHIBITOR CERIVASTATIN

      Naunyn-Schmiedeberg's archives of pharmacology
    49. VORMFELDE SV; GLEITER CH; FREUDENTHALER S; MUCK W; SCHMAGE N; KUHLMANN J; GUNDERTREMY U
      PHARMACOKINETICS OF SINGLE-DOSE CERIVASTATIN IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION

      Atherosclerosis
    50. KUHLMANN J; MACARA I; WITTINGHOFER A
      DYNAMIC AND EQUILIBRIUM STUDIES ON THE INTERACTION OF RAN WITH ITS EFFECTOR, RANBP1

      Biochemistry
    51. VERSAVEL M; VANLAACK D; EVERTZ C; UNGER S; MEIER F; KUHLMANN J
      TEST-RETEST RELIABILITY AND INFLUENCE OF PRACTICE EFFECTS ON PERFORMANCE IN A MULTIUSER COMPUTERIZED PSYCHOMETRIC TEST SYSTEM FOR USE IN CLINICAL PHARMACOLOGICAL STUDIES

      Arzneimittel-Forschung
    52. POHLERS D; VOLPONI C; SCHMIDTWEBER CB; KUHLMANN J; EMMRICH F; KINNE RW
      DIFFERENTIAL CLINICAL EFFICACY OF 3 ANTI-RAT CD4 MONOCLONAL-ANTIBODIES (MABS) IN THE PREVENTION OF RAT ADJUVANT ARTHRITIS (AA)

      Arthritis and rheumatism
    53. MUCK W; BREUEL HP; KUHLMANN J
      THE INFLUENCE OF AGE ON THE PHARMACOKINETICS OF NIMODIPINE

      International journal of clinical pharmacology and therapeutics
    54. MUCK W; TANAKA T; AHR G; KUHLMANN J
      NO INTERETHNIC DIFFERENCES IN STEREOSELECTIVE DISPOSITION OF ORAL NIMODIPINE BETWEEN CAUCASIAN AND JAPANESE SUBJECTS

      International journal of clinical pharmacology and therapeutics
    55. WENSING G; HEINIG R; KUHLMANN J
      PHARMACODYNAMICS AND PHARMACOKINETICS OF BAY-X-7195 AEROSOL, A NEW AND SELECTIVE RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, IN NORMAL VOLUNTEERS

      British journal of clinical pharmacology
    56. SCHAEFER HG; STASS H; WEDGWOOD J; HAMPEL B; FISCHER C; KUHLMANN J; SCHAAD UB
      PHARMACOKINETICS OF CIPROFLOXACIN IN PEDIATRIC CYSTIC-FIBROSIS PATIENTS

      Antimicrobial agents and chemotherapy
    57. ARNAUD J; CHENU C; HUCHENQ A; GOUAILLARD C; KUHLMANN J; RUBIN B
      DEFECTIVE INTERACTIONS BETWEEN TCR CHAINS AND CD3 HETERODIMERS PREVENT MEMBRANE EXPRESSION OF TCR-ALPHA-BETA IN HUMAN T-CELLS

      The Journal of immunology
    58. EHRICH M; KUHLMANN J; NETZLER D; STOHR C
      TIME-DOMAIN INVESTIGATION OF THE TRANSIENT-BEHAVIOR OF A CIRCULAR TUBE 2-WIRE LINE

      IEEE transactions on magnetics
    59. VERSAVEL M; VANLAACK D; EVERTZ C; MEIER F; KUHLMANN J
      EFFECT OF EDUCATIONAL-LEVEL, GENDER AND AGE ON THE PERFORMANCE IN A MULTIUSER COMPUTERIZED PSYCHOMETRIC TEST SYSTEM FOR USE IN CLINICAL PHARMACOLOGICAL STUDIES

      Arzneimittel-Forschung
    60. MUCK W; AHR G; KUHLMANN J
      NIMODIPINE - POTENTIAL FOR DRUG-DRUG INTERACTIONS IN THE ELDERLY

      Drugs & aging
    61. DOBOS GJ; KUHLMANN J; BOHLER J; SACH M; PASSLICKDEETJEN J; SCHOLLMEYER PJ
      BICARBONATE-BASED DIALYSIS SOLUTION IMPROVES FMLP-STIMULATED SUPEROXIDE PRODUCTION IN NEUTROPHILS, DESPITE IN-VITRO BUFFERING CAPACITY

      Journal of the American Society of Nephrology
    62. SCHAEFER HG; AHR G; KUHLMANN J
      PHARMACOKINETIC DEVELOPMENT OF QUINOLONE ANTIBIOTICS

      International journal of clinical pharmacology and therapeutics
    63. BREUEL HP; HEINE PR; MUCK W; NIKLAUS H; SCHMAGE N; KUHLMANN J
      CHRONIC ADMINISTRATION OF NIMODIPINE AND PROPRANOLOL IN ELDERLY NORMOTENSIVE SUBJECTS - AN INTERACTION STUDY

      International journal of clinical pharmacology and therapeutics
    64. BREUEL HP; MUCK W; HEINE PR; SCHMAGE N; NIKLAUS H; KUHLMANN J
      THE INFLUENCE OF NIMODIPINE ON HEMODYNAMIC PARAMETERS AND PEAK AND TROUGH PLASMA-CONCENTRATIONS OF NIFEDIPINE CHRONICALLY ADMINISTERED TO ELDERLY HYPERTENSIVE PATIENTS

      International journal of clinical pharmacology and therapeutics
    65. HEINIG R; SCHAEFER HG; WENSING G; KUHLMANN J
      PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE ORALLY-ADMINISTERED RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES BAY-X-7195 IN SINGLE-DOSE ESCALATION STUDIES

      International journal of clinical pharmacology and therapeutics
    66. KINNE RW; BECKER W; KOSCHECK T; KUHLMANN J; SHARKEY RM; BEHR T; PALOMBOKINNE E; GOLDENBERG DM; WOLF F; EMMRICH F
      RAT ADJUVANT ARTHRITIS - IMAGING WITH TECHNETIUM-99M-ANTI-CD4 FAB' FRAGMENTS

      The Journal of nuclear medicine
    67. ADELMANN HG; RITTER W; KUHLMANN J
      PHARMACODYNAMIC EFFECTS OF BAY-Y-5959, A NEW POSITIVE INOTROPIC CALCIUM PROMOTOR AFTER INTRAVENOUS ADMINISTRATION TO HEALTHY-YOUNG VOLUNTEERS

      Clinical pharmacology and therapeutics
    68. DOBOS GJ; BOHLER J; SACH M; KUHLMANN J; SPATH M; ANDRE M; PASSLICKDEETJEN J; SCHOLLMEYER PJ
      BICARBONATE-BASED DIALYSIS SOLUTION IMPROVES CALCIUM MOBILIZATION IN FMLP-STIMULATED NEUTROPHILS

      Journal of the American Society of Nephrology
    69. KUHLMANN J
      DRUG-INTERACTION STUDIES DURING DRUG DEVELOPMENT - WHICH, WHEN, HOW

      International journal of clinical pharmacology and therapeutics
    70. DOBOS GJ; BOHLER J; KUHLMANN J; ELSNER J; ANDRE M; PASSLICKDEETJEN J; SCHOLLMEYER PJ
      BICARBONATE-BASED DIALYSIS SOLUTION PRESERVES GRANULOCYTE FUNCTIONS

      Peritoneal dialysis international
    71. HEINE PR; WEYER G; BREUEL HP; MUCK W; SCHMAGE N; KUHLMANN J
      LACK OF INTERACTION BETWEEN DIAZEPAM AND NIMODIPINE DURING CHRONIC ORAL-ADMINISTRATION TO HEALTHY ELDERLY SUBJECTS

      British journal of clinical pharmacology
    72. KOHR HU; KUHLMANN J; LIPPERT E; SEIFERT R
      HANDBOOK OF MILITARY PSYCHOLOGY - GAL,R, MANGELSDORFF,AD

      Armed forces and society
    73. WENSING G; HEINIG R; PRIESNITZ M; KUHLMANN J
      EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS

      European Journal of Clinical Pharmacology
    74. WENSING G; HEINIG R; PRIESNITZ M; KUHLMANN J
      EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS

      European Journal of Clinical Pharmacology
    75. HOU XH; DIETRICH J; KUHLMANN J; WEGENER AMK; GEISLER C
      STRUCTURE OF THE T-CELL RECEPTOR IN A TI-ALPHA-V-BETA-2,ALPHA-V-BETA-8-POSITIVE T-CELL LINE

      European Journal of Immunology
    76. WENSING G; HEINIG R; KUHLMANN J
      EFFECT OF THE LEUKOTRIENE D-4 (LTD(4))-RECEPTOR ANTAGONIST BAY X 7195ON LTD(4)-INDUCED BRONCHOCONSTRICTION IN NORMAL SUBJECTS

      Clinical pharmacology and therapeutics
    77. STACHER G; WEIHRAUCH TR; WIENBECK M; EMDE C; JANSSENS J; JANISCH HD; MITTAL RK; BOESBY S; AKKERMANS LMA; FEUSSNER H; MERKI HLS; EVANDER A; SMOUT AJPM; KUHLMANN J; BALDI F
      ESOPHAGEAL MANOMETRY - METHODS AND VALUE IN SCIENCE AND CLINICAL-PRACTICE .2. STANDARDIZATION OF THE PROCEDURE - DISCUSSION - SESSION-II

      Digestive diseases and sciences
    78. KUHLMANN J; KONRADDALHOFF I; WEIHRAUCH TR
      WHICH DRUGS SHOULD BE STUDIED BY PHARMACOMANOMETRY

      Digestive diseases and sciences
    79. KONRADDALHOFF I; BAUNACK AR; WEIHRAUCH TR; KUHLMANN J
      INFLUENCE OF MIGRATING MOTOR COMPLEX ON ESOPHAGEAL MOTILITY

      Digestive diseases and sciences
    80. BALDI F; JANISCH HD; KUHLMANN J; STACHER G; ERCKENBRECHT JF; SMOUT AJPM; FEUSSNER H; WEIHRAUCH TR; BAUNACK AR; MITTAL RK; JANSSENS J; EMDE C; KONRADDALHOFF I; AKKERMANS LMA
      ESOPHAGEAL MANOMETRY - METHODS AND VALUE IN SCIENCE AND CLINICAL-PRACTICE .3. DRUG EFFECTS ON ESOPHAGEAL SMOOTH-MUSCLE - DISCUSSION - SESSION-III

      Digestive diseases and sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 06:44:14